Seasoned European investment professional and former operating executive focused on buyouts, growth equity and corporate finance advisory. Philippe Reitzer brings cross-border deal experience, portfolio company oversight, and capital-raising expertise to institutional investors and corporate boards. Known for sourcing mid-market opportunities, executing operational turnarounds and structuring complex financing solutions, he is active in value-creation programs and board governance, with a background spanning investment banking, private equity and operational leadership.
Seasoned European investment professional and former operating executive focused on buyouts, growth equity and corporate finance advisory. Philippe Reitzer brings cross-border deal experience, portfolio company oversight, and capital-raising expertise to institutional investors and corporate boards. Known for sourcing mid-market opportunities, executing operational turnarounds and structuring complex financing solutions, he is active in value-creation programs and board governance, with a background spanning investment banking, private equity and operational leadership.
Adopts a pragmatic, value-oriented private markets approach combining operational playbooks with structured finance to unlock mid-market opportunities across Europe. Focuses on buyouts and growth equity where operational interventions and tailored capital structures increase cash flow and accelerate scalable growth. Prefers cross-border situations, complex carve-outs and turnaround engagements; emphasizes thorough due diligence, active board-level oversight, and KPI-driven management plans. Capital deployment favors control or significant minority positions with 3–7 year horizons, disciplined leverage, staged financing and clear exit pathways to maximize risk-adjusted returns.
Adopts a pragmatic, value-oriented private markets approach combining operational playbooks with structured finance to unlock mid-market opportunities across Europe. Focuses on buyouts and growth equity where operational interventions and tailored capital structures increase cash flow and accelerate scalable growth. Prefers cross-border situations, complex carve-outs and turnaround engagements; emphasizes thorough due diligence, active board-level oversight, and KPI-driven management plans. Capital deployment favors control or significant minority positions with 3–7 year horizons, disciplined leverage, staged financing and clear exit pathways to maximize risk-adjusted returns.
| Trades 2552 | Longs Won 1529/2552 59% | Profit Factor 3.41 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $6.67M |
| Average Win $1.06M | Best Trade (Oct 15) $212.49M | Sharpe Ratio -20.45 |
| Average Loss -$466,310.8 | Worst Trade (Jun 30) -$55.37M | Z-Score 1.63 (89.79%) |
| Commissions $0 | Avg. Trade Length 6m 2w 6d | Expectancy $450,160.95 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 10,309 | 9,278 | 8,247 | 7,216 | 6,186 | 5,155 | 4,124 | 3,093 | 2,062 | 1,031 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 400 | $46,792 | $69,312 | - | $22,520 | 48.13% | -1.293% |
AAPL Apple Inc. | 1.06M | $238.43M | $363.5M | - | $125.07M | 52.46% | +0.231% |
ABBV AbbVie Inc. | 5,858 | $1.27M | $1.67M | - | $400,853.12 | 31.59% | +0.568% |
ABT Abbott Laboratories | 31,530 | $3.78M | $3.3M | - | -$479,598.26 | -12.7% | -0.091% |
ACGL Arch Capital Group Ltd | 3,396 | $311,110.61 | $340,618.8 | - | $29,508.19 | 9.48% | +0.997% |
ACN Accenture plc Class A | 5,948 | $1.17M | $1.34M | - | $162,801.48 | 13.89% | -0.205% |
ACWI iShares MSCI ACWI ETF | 60 | $9,418 | $9,461.4 | - | $43.4 | 0.46% | -0.967% |
ADBE Adobe Inc. | 18,289 | $6.55M | $4.46M | - | -$2.09M | -31.89% | -3.004% |
ADI Analog Devices, Inc. | 1,680 | $535,327.83 | $678,619.2 | - | $143,291.37 | 26.77% | -0.002% |
ADSK Autodesk, Inc. | 348 | $77,495.64 | $82,897.08 | - | $5,401.44 | 6.97% | -2.835% |
AEM Agnico Eagle Mines Limited | 48 | $8,645.63 | $8,972.16 | - | $326.53 | 3.78% | -0.341% |
AEP American Electric Power Company, Inc. | 180 | $16,509 | $22,761 | - | $6,252 | 37.87% | +1.738% |
AEYE AudioEye, Inc. | 100 | $603 | $671 | - | $68 | 11.28% | -4.143% |
AIG American International Group Inc. | 6,640 | $499,660 | $531,731.2 | - | $32,071.2 | 6.42% | +1.213% |
AIQ Global X Artificial Intelligence & Technology ETF | 11,928 | $782,596 | $740,788.44 | - | -$41,807.56 | -5.34% | -3.097% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 10,794 | $1.18M | $3.09M | - | $1.91M | 161.07% | -5.272% |
ALC Alcon Inc. | 91 | $6,733 | $6,027.84 | - | -$705.16 | -10.47% | -0.511% |
ALGN Align Technology, Inc. | 29 | $4,606.94 | $4,285.91 | - | -$321.03 | -6.97% | -1.038% |
ALLE Allegion plc | 8,043 | $1.17M | $1.25M | - | $82,159.96 | 7.04% | -0.225% |
ALNY Alnylam Pharmaceuticals Inc | 692 | $224,486.55 | $161,374.4 | - | -$63,112.15 | -28.11% | -0.355% |